ACH (Accendra Health, Inc.) Stock | Pipeline, Insider Trades & Financials

Jul 27, 2026

▲ +5.1%today

Accendra Health Announces Second Quarter 2026 Earnings Release Date and Conference Call

Accendra Health, Inc. has announced the release date for its second quarter 2026 earnings report, which will be available on August 10, 2026, before market trading begins. The company will also hold a conference call for investors and analysts at 8:00 a.m. EDT on the same day, offering a platform for discussion and inquiries.

Jun 24, 2026

Accendra Health Announces Expiration and Final Results of Offers and Consent Solicitations

Accendra Health has announced the expiration and final results of its offers and consent solicitations. The details regarding the outcomes of these solicitations have not been disclosed in the provided text. Further information may be required for a comprehensive understanding of the implications.

Jun 10, 2026

Accendra Health Announces Early Results of Offers and Consent Solicitations

Accendra Health has announced early results of its offers and consent solicitations. However, the article does not provide specific details regarding the outcomes or implications of these results. The announcement appears to be part of ongoing corporate activities.

May 22, 2026

Accendra Health Announces Offers and Consent Solicitations

Accendra Health has announced offers and consent solicitations. However, the article does not provide further details on the nature or implications of these announcements. The lack of specific information leaves the overall sentiment neutral.

Accendra Health Reports First Quarter 2026 Financial Results and Announces Comprehensive Balance Sheet Optimization Transaction

Accendra Health has released its financial results for the first quarter of 2026, alongside a significant balance sheet optimization transaction. The report highlights the company's efforts to enhance its financial position. Further details on the transaction and its implications for future performance were not provided.

Project Huskies Management Presentation May 2026 THIS PRESENTATION MAY CONTAIN MATERIAL NON-PUBLIC INFORMATION CONCERNING THE COMPANY (AS DEFINED HEREIN) AND ITS SUBSIDIARIES. BY ACCEPTING THIS PRESENTATION, THE RECIPIEN

Accendra Health has released a confidential management presentation outlining various aspects of the company and its strategic plans as of May 2026. The presentation emphasizes that it may contain material non-public information and outlines confidentiality obligations for recipients. Additionally, it includes forward-looking statements related to the company's performance and expectations, though the company disclaims any assurances regarding these projections. Potential investors are warned about the uncertainties surrounding these forward-looking statements and encouraged to review risk factors in their SEC filings.

Feb 19, 2026

Accendra Health Reports Fourth Quarter 2025 Financial Results Completed Sale of Products & Healthcare Services Business On

Accendra Health, Inc. reported its financial results for the fourth quarter of 2025, highlighting the completion of the sale of its Products & Healthcare Services segment. This transaction is expected to pave the way for a more focused operation, with the company's leadership expressing optimism about future growth and value creation. Despite a strong revenue performance in the fourth quarter, the company still reported a loss from continuing operations, indicating ongoing financial challenges. The outlook for 2026 includes goals for improved cash flow and balance sheet optimization amidst potential market uncertainties.

Owens & Minor, Inc. Completes Sale of Products & Healthcare Services Business to Platinum Equity The Transaction Includes the Owens & Minor Brand, and the Remaining Company Will Become Accendra Health Completes the Compa

Owens & Minor, Inc. has completed the sale of its Products & Healthcare Services segment to Platinum Equity for $375 million, marking a strategic shift for the company. Following this transaction, the company will be renamed Accendra Health, focusing on home-based care solutions. The leadership believes this move will strengthen their market position and operational execution in supporting chronic condition management. The sale is also structured to preserve certain tax attributes beneficial for the company’s future.

Dec 18, 2025

Owens & Minor Announces Corporate Name Change to Accendra Health, Inc. Accendra Health To Trade Under the "ACH" Symbol on the New York Stock Exchange RICHMOND, VA

Owens & Minor, Inc. has announced that it will change its name to Accendra Health, Inc. effective December 31, 2025. This name change is part of the company's strategic shift to focus on the home-based care market, while continuing to use current brands like Apria and Byram Healthcare. Along with the name change, the company will adopt the ticker symbol "ACH" on the New York Stock Exchange starting January 2, 2026. The organization aims to enhance its market position and reflect its commitment to high-quality patient care through this rebranding.

Dec 2, 2025

Owens & Minor to Present at Upcoming Investor Conferences on

Owens & Minor, Inc. announced its participation in two investor conferences on December 2, 2025, in Miami and Boca Raton, Florida. Key executives, including CEO Ed Pesicka and CFO Jon Leon, will be involved in discussions and one-on-one meetings with investors. These events provide a platform for the company to communicate its strategic goals and engage with stakeholders.

Oct 30, 2025

Owens & Minor Reports Third Quarter 2025 Financial Results Signed Definitive Agreement for the Sale of Products & Healthcare Services Segment Transaction Positions the Company as a Pure-Play Home-Based Care Business RICH

Owens & Minor, Inc. has reported its financial results for the third quarter of 2025, showing a focus on transitioning to a pure-play home-based care business following the sale of its Products & Healthcare Services segment. The company expressed confidence in its growth strategy centered around its Patient Direct platform and has engaged in a nationwide preferred provider partnership. However, Owens & Minor faced a considerable net loss for the quarter, raising concerns about its financial stability amidst ongoing restructuring efforts. The outlook for future financial results is clouded by uncertainties regarding GAAP measures due to unpredictable costs.

Oct 7, 2025

Owens & Minor Announces Definitive Agreement to Divest Products & Healthcare Services Segment to Platinum Equity for $375mm in Cash and a Retained Equity Stake Transforms Owens & Minor into a Pure Play Market Leader in t

Owens & Minor has finalized an agreement to divest its Products & Healthcare Services segment to Platinum Equity for $375 million in cash, while retaining a 5% equity stake. This strategic move aims to simplify Owens & Minor's business model and enhance its focus on the burgeoning home-based care market. The transaction also includes preserving essential tax attributes worth over $150 million, highlighting the financial prudence of the deal. The expected closing of this transaction is slated for the end of 2025, pending customary regulatory approvals.

Aug 11, 2025

Owens & Minor Reports Second Quarter 2025 Financial Results Classified Products & Healthcare Services Segment as Discontinued Operations Continuing Operations, Patient Direct, Showed Solid Performance and Growth RICHMOND

Owens & Minor, Inc. reported its financial results for the second quarter of 2025, indicating a loss from continuing operations and a classification of its Products & Healthcare Services segment as discontinued operations due to an impending sale. The Patient Direct segment showed solid performance, leading the company to position itself as a pure-play entity in this space. While there are positive expectations for future growth in the Patient Direct area, significant financial losses and ongoing uncertainties related to the divestiture raise concerns about the company's outlook.

Jun 5, 2025

Owens & Minor and Rotech Healthcare Mutually Agree to Terminate Previously Announced Acquisition OMI Remains Committed to Continued Growth in the Strong Home-based Care Market Will Focus on Deleveraging & Driving Profita

Owens & Minor has mutually agreed with Rotech Healthcare to terminate their acquisition, which involved a payment of $80 million. The company faced challenges in obtaining regulatory clearance, making the merger unfeasible in terms of time and costs. Despite this setback, Owens & Minor is committed to growing its Patient Direct business and improving its financial health through deleveraging. The home-based care market remains a focal point for the company as they continue to explore opportunities for strengthening their business.

May 8, 2025

Owens & Minor Reports First Quarter 2025 Financial Results Top-Line Growth Led by the Patient Direct Segment Patient Direct Operating Margin Expanded by 173 Basis Points Company Reaffirmed 2025 Financial Guidance Remain

Owens & Minor, Inc. has reported its financial results for the first quarter of 2025, indicating a slight increase in revenue driven primarily by the Patient Direct segment. The segment achieved mid-single digit top-line growth and an expanded operating margin. Despite this growth, the company reported a net loss that increased compared to the previous year, prompting concerns regarding future profitability and potential impacts from government policy changes. The company has reaffirmed its financial outlook for 2025 while remaining engaged in the sale process of its Products & Healthcare Services segment.

Apr 2, 2025

Owens & Minor Announces Upsize and Pricing of Senior Secured Notes Offering

Owens & Minor has announced an upsized and priced offering of $1 billion in senior secured notes due in 2030, aimed at financing its acquisition of Rotech Healthcare Holdings. The notes, which carry a 10.000% interest rate, are set to close on April 4, 2025. The success of the offering is contingent upon the acquisition's completion, which is subject to customary closing conditions and regulatory approvals. Proceeds will initially be held in escrow until the acquisition is finalized.

Mar 26, 2025

Owens & Minor Announces Launch of Senior Secured Notes Offering

Owens & Minor, Inc. has initiated a private offering of $600 million in senior secured notes due in 2030. This offering is intended to finance the acquisition of Rotech Healthcare Holdings Inc., although it is subject to customary closing conditions. Gross proceeds from the offering will be placed in a segregated escrow account until specific conditions are fulfilled. The notes carry guarantees from the company and are secured by first-priority interests, although completion of the acquisition remains uncertain.

Mar 20, 2025

Disclaimer Forward-Looking Statements This presentation contains certain "forward-looking" statements made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. Some of these sta

Owens & Minor, Inc. has entered into an agreement to acquire Rotech Healthcare Holdings, Inc. This transaction aims to improve Owens & Minor's competitiveness in the home healthcare market. However, the process faces risks, including regulatory scrutiny and potential operational disruptions. Financially, the companies expect to perform better as a combined entity, although challenges in integration and achieving expected synergies remain.

Feb 28, 2025

Owens & Minor Reports Fourth Quarter & Full Year Financial Results and Announces Sale Process Underway for Products & Healthcare Services Segment Total Debt Reduction of $244 Million in 2024, Capping a Two-Year Total Deb

Owens & Minor has reported its financial results for Q4 and full year 2024, highlighting a substantial planned debt reduction of $244 million. The company is engaging in active discussions for the sale of its Products & Healthcare Services segment while aiming for double-digit adjusted EBITDA growth in 2025. Additionally, a $100 million share repurchase program has been authorized, reflecting the board's confidence in the future. Despite some losses and a goodwill impairment charge, the outlook remains optimistic due to positive trends in the Patient Direct segment.

Feb 3, 2025

Owens & Minor Launches Financing for Rotech Acquisition and Provides Preliminary Fourth Quarter and Full Year 2024 Financial Results Ahead of Investor Meetings Expects to Report Fourth Quarter and Full Year 2024 Financia

Owens & Minor has initiated financing for the acquisition of Rotech Healthcare amidst releasing preliminary financial results for Q4 and the full year 2024. The company expects to close the Rotech acquisition in the first half of 2025. Preliminary results indicate a net loss and anticipated goodwill impairment charges, though the management highlighted strong cash flow and growth in their Patient Direct segment as positive indicators. A conference call for more detailed results is scheduled for February 28, 2025.

Nov 4, 2024

Owens & Minor Reports Third Quarter 2024 Financial Results Top-Line Growth Driven by Continued Solid Demand in Patient Direct and Medical Distribution Total Debt Reduction of Nearly $200 Million in the Third Quarter RICH

Owens & Minor, Inc. reported its financial results for the third quarter of 2024, showcasing a nearly 5% increase in revenue from the previous year and notable debt reduction of almost $200 million. The company highlighted strong performance in the Patient Direct segment and positive trends in its Medical Distribution division. However, despite these successes, Owens & Minor reported a larger net loss compared to the same quarter last year, attributed to continued economic pressures. Management remains optimistic about future growth and cash flow as they move into 2025.

Sep 23, 2024

Owens & Minor Names Jonathan Leon Executive Vice President, Chief Financial Officer RICHMOND, VA

Owens & Minor, Inc. has appointed Jonathan Leon as the Executive Vice President and Chief Financial Officer, effective immediately. Leon, who has been with the company since 2017, will also continue his duties as Corporate Treasurer while the search for his successor takes place. With over 25 years of experience in corporate finance, Leon's comprehensive background includes senior roles at Owens & Minor and The Brink's Company. His appointment is seen as a strategic move to support the company's long-term goals as highlighted during the recent Investor Day.

Aug 2, 2024

Owens & Minor Reports Second Quarter 2024 Financial Results Top Line Expansion Driven by Solid Growth in Both Segments Second Quarter Operating Cash Flow of $116 Million Drove $71 million in Debt Reduction Expanding Pati

Owens & Minor, Inc. reported its financial results for the second quarter of 2024, showing revenue growth and a significant operating cash flow. The company noted a top line expansion driven by solid growth in both its Medical Distribution and Patient Direct segments, with a recent agreement to acquire Rotech Healthcare Holdings. However, the financials were affected by a net loss of $31.9 million and a one-time income tax charge of $17 million. The company reaffirms its financial outlook for 2024 despite the challenges presented by economic conditions and market pressures.

Jul 23, 2024

Owens & Minor, Inc. Signs Definitive Agreement to Acquire Rotech Healthcare Holdings, Inc. for $1.36 Billion in Cash Strategy Articulated at Investor Day is Advanced by Strengthening Our Patient Direct s Position as a Pr

Owens & Minor, Inc. has entered into a definitive agreement to acquire Rotech Healthcare Holdings, Inc. for $1.36 billion in cash. This acquisition is aimed at enhancing Owens & Minor's capabilities in home-based care, aligning with their strategic goals discussed during the Investor Day. The deal is projected to result in a tax benefit of around $40 million, reducing the net purchase price to $1.32 billion. The expected closing date for the transaction is by the end of 2024, subject to customary conditions.

Jul 23, 2024

Owens & Minor, Inc. Releases Preliminary Second Quarter 2024 Financial Results & Reaffirms 2024 Annual Guidance Plans to Release Full Results on Friday, August 2 Before the NYSE Open RICHMOND, VA

Owens & Minor, Inc. released preliminary financial results for the second quarter of 2024, reporting expected revenue between $2,651 million and $2,671 million and indicating a GAAP net loss ranging from $35 million to $32 million. Despite the net loss, the company reaffirmed its financial outlook for 2024. A one-time income tax charge of $17 million may have impacted the results, but they anticipate concluding related matters without further adverse effects on financials. Full results will be announced on August 2, 2024, prior to the market opening.

May 3, 2024

Owens & Minor Reports First Quarter 2024 Financial Results Gross Margin Expansion of 79 Basis Points Adjusted EPS Growth of Nearly Four Times with GAAP EPS Loss of $(0.29) and Adjusted EPS of $0.19 Investments Outlined a

Owens & Minor, Inc. has reported its financial results for the first quarter of 2024, showcasing growth in adjusted EPS and an expansion in gross margins. Revenue reached $2.613 billion, representing an increase from the previous year. While the company experienced a loss as per GAAP EPS, adjusted earnings reflect a strong performance. Strategic investments are reportedly ahead of schedule, despite challenges such as inflation and pricing pressures affecting future forecasts.

Feb 20, 2024

Owens & Minor Reports Fourth Quarter and Full Year 2023 Financial Results Business Delivered Strong Operating Margin Improvement in Fourth Quarter Robust Full Year Operating Cash Flow Generation Enabled Significant Debt

Owens & Minor, Inc. reported its financial results for the fourth quarter and full year of 2023, demonstrating strong operating margin improvements and robust cash flow generation. The company saw significant top-line growth across both of its business segments, particularly in the Patient Direct segment. However, it also reported a net loss for the full year and is cautious about economic conditions affecting its 2024 outlook, which anticipates pricing pressure and variable demand in its Products & Healthcare Services segment.

Dec 6, 2023

Owens & Minor Owens & Minor Unveils Long-Term Strategy at Investor Day Today Outlines new five-year strategic plan intended to unlock expanded profitability and growth profiles of the business, targeting 20% compounded e

Owens & Minor unveiled its new long-term strategy during its Investor Day event, aiming for 20% compounded earnings growth from 2024 to 2028. The plan focuses on enhancing profitability through disciplined capital allocation and strategic investments, particularly in its Patient Direct segment. The company expressed optimism about its potential to maximize growth and shareholder value, despite acknowledging risks related to forecasting GAAP metrics and uncertainties affecting future financial performance.

Oct 12, 2022

Owens & Minor Announces Executive Leadership Team Changes Company also Provides Preliminary Results for the 3 rd Quarter and Updated Guidance for 2022 RICHMOND, VA

Owens & Minor Announces Executive Leadership Team Changes Company also Provides Preliminary Results for the 3rd Quarter and Updated Guidance RICHMOND, VA October 12, 2022 Owens & Minor, Inc. (NYSE-OMI) today announced certain changes to its executive leadership team, including

Mar 29, 2022

INDEX TO FINANCIAL STATEMENTS Audited Consolidated Financial Statements of Apria, Inc. Report of Independent Registered Public Accounting Firm (PCAOB ID 34) 2 Consolidated Balance Sheets as of

INDEX TO FINANCIAL STATEMENTS Audited Consolidated Financial Statements of Apria, Inc. Report of Independent Registered Public Accounting Firm (PCAOB ID 34) 2 Consolidated Balance Sheets as of December 31, 2021 and December 31, 2020 4 Consolidated Statements of Income

Mar 23, 2022

Owens & Minor Announces Upsize and Pricing of $600 Million of Senior Notes due 2030 RICHMOND, VA (Business Wire)

Owens & Minor Announces Upsize and Pricing of $600 Million of Senior Notes due 2030 RICHMOND, VA (Business Wire) March 23, 2022 - Owens & Minor, Inc. (NYSE:OMI) (the Company ) announced today the upsize and pricing of its private offering (the Offering ) of $600 million aggrega

Mar 18, 2022

OWENS & MINOR ANNOUNCES LAUNCH OF SENIOR NOTES OFFERING RICHMOND, VA - (Business Wire)

OWENS & MINOR ANNOUNCES LAUNCH OF SENIOR NOTES OFFERING RICHMOND, VA - (Business Wire) - March 18, 2022 - Owens & Minor, Inc. (NYSE:OMI) (the Company ) announced today that it has launched a private offering (the Offering ) of $500 million aggregate principal amount of senior n

Feb 28, 2022

Investor Presentation

2022 Confidential & Proprietary to Owens & Minor, Inc. 1 This presentation contains certain "forward looking" statements made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. These statements include, but are not limited to, statem

Jan 10, 2022

OWENS & MINOR, INC. SIGNS DEFINITIVE AGREEMENT TO ACQUIRE APRIA, INC. Highly Complementary Transaction Expands Patient Direct Offering Year-One Accretion Across Key Financial Metrics and Free Cash Flow Enhancement Create

OWENS & MINOR, INC. SIGNS DEFINITIVE AGREEMENT TO ACQUIRE APRIA, INC. Highly Complementary Transaction Expands Patient Direct Offering Year-One Accretion Across Key Financial Metrics and Free Cash Flow Enhancement Creates a Leading Platform for Future Growth RICHMOND, Va. and

Mar 4, 2021

Owens & Minor Announces Pricing of $500 Million of Senior Notes due 2029 RICHMOND, VA. (

Owens & Minor Announces Pricing of $500 Million of Senior Notes due 2029 RICHMOND, VA. (March 3, 2020) - Owens & Minor, Inc. (NYSE:OMI) (the Company ) announced today the pricing of its private offering (the Offering ) of $500 million aggregate principal amount of its 4.500% se

Mar 2, 2021

OWENS & MINOR ANNOUNCES LAUNCH OF SENIOR NOTES OFFERING RICHMOND, VA. (

OWENS & MINOR ANNOUNCES LAUNCH OF SENIOR NOTES OFFERING RICHMOND, VA. (March 2, 2021) - Owens & Minor, Inc. (NYSE:OMI) (the Company ) announced today that it has launched a private offering (the Offering ) of $500 million aggregate principal amount of senior notes due 2029 (the

Feb 24, 2021

Document Two New Members Elected to Owens Minor Board of Directors

Two New Members Elected to Owens Minor Board of Directors RICHMOND, Va.--(BUSINESS WIRE) -- Owens Minor, Inc. (NYSE OMI), a leading global healthcare solutions company, today announced the election of Aster Angagaw and Stephen W. Klemash to its Board of Directors. These additio

Mar 5, 2020

Use of Non-GAAP Measures The foregoing tables contain financial measures that are not calculated in accordance with U.S. generally accepted accounting principles ("GAAP"). In general, the measures exclude items and charg

Summary Financial Information on a Continuing Operations Basis (unaudited) The unaudited summary financial information below is provided to reflect the Company's results on a continuing operations basis for the four quarters and year ended December 31, 2019. Beginning with the A

Nov 8, 2018

Owens & Minor Names Board Member Robert Sledd Chairman and Interim President and CEO Company Commences Search for Permanent

Owens & Minor Names Board Member Robert Sledd Chairman and Interim President and CEO Company Commences Search for Permanent CEO RICHMOND, VA - November 8, 2018 - Owens & Minor Inc. (NYSE: OMI) announced today that Robert C. Sledd, a member of the company's board of directors, h

Apr 9, 2018